Health Catalyst Shares Outstanding 2018-2023 | HCAT
Health Catalyst shares outstanding from 2018 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Health Catalyst Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 56 |
| 2022 | 54 |
| 2021 | 47 |
| 2020 | 40 |
| 2019 | 19 |
| 2018 | 5 |
| 2017 | 5 |
| Health Catalyst Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 56 |
| 2023-09-30 | 57 |
| 2023-06-30 | 56 |
| 2023-03-31 | 55 |
| 2022-12-31 | 54 |
| 2022-09-30 | 54 |
| 2022-06-30 | 54 |
| 2022-03-31 | 53 |
| 2021-12-31 | 47 |
| 2021-09-30 | 49 |
| 2021-06-30 | 45 |
| 2021-03-31 | 44 |
| 2020-12-31 | 40 |
| 2020-09-30 | 40 |
| 2020-06-30 | 38 |
| 2020-03-31 | 37 |
| 2019-12-31 | 19 |
| 2019-09-30 | 28 |
| 2019-06-30 | 5 |
| 2019-03-31 | 5 |
| 2018-12-31 | |
| 2018-09-30 | 5 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.328B | $0.296B |
| Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.087B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.621B | 0.00 |
| Axonics (AXNX) | United States | $3.390B | 0.00 |
| 10x Genomics (TXG) | United States | $3.287B | 0.00 |
| Enovis (ENOV) | United States | $3.042B | 23.11 |
| Azenta (AZTA) | United States | $2.930B | 238.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.760B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.642B | 0.00 |
| Privia Health (PRVA) | United States | $2.231B | 98.95 |
| Schrodinger (SDGR) | United States | $1.794B | 0.00 |
| Omnicell (OMCL) | United States | $1.306B | 31.94 |
| Phreesia (PHR) | United States | $1.305B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.856B | 0.00 |
| Standard BioTools (LAB) | United States | $0.743B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.617B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.330B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.162B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.157B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.154B | 0.00 |
| Augmedix (AUGX) | United States | $0.138B | 0.00 |
| Outset Medical (OM) | United States | $0.127B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.06 |
| 111 (YI) | China | $0.091B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |